GSK's severe pediatric asthma drug wins European panel thumbs-up Ruby Khatun Khatun30 July 2018 10:00 AM ISTGlaxoSmithKline (GSK) drug Nucala has won a key recommendation from a European Medicines Agency (EMA) panel for use in the treatment of children with...
Morepen Labs gets USFDA nod for asthma drug Ruby Khatun Khatun21 Dec 2017 2:09 PM ISTNew Delhi: Morepen Laboratories said the US health regulator has given approval to Montelukast Sodium, used in managing asthma symptoms and seasonal...
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis Ruby Khatun Khatun15 Dec 2017 10:06 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis...
Cipla launches 2 digital education platforms-Ciplamed and Breathefree Ruby Khatun Khatun14 Dec 2017 11:00 AM ISTMumbai: In continuation to its commitment to patient-centricity and digitization, Cipla announces the launch of two digital assets, one aimed at...
New AstraZeneca, Amgen drug looks strong rival in severe asthma Ruby Khatun Khatun11 Sept 2017 10:27 AM ISTLONDON: A new kind of injectable biotech treatment for severe asthma from AstraZeneca and Amgen promises to help a much broader range of patients than...
Propeller Health and GSK expands digital health collaboration for Asthma and COPD Ruby Khatun Khatun28 Aug 2017 9:15 AM ISTMADISON: Propeller Health, a leading digital solution for respiratory medicine, today announced the expansion of its 2015 collaboration with GSK,...
